These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2649207)

  • 21. [Effects of the stimulation of D1 and D2 dopaminergic receptors on the electrically induced release of gamma-(3H)-aminobutyric acid in the prefrontal cortex of the rat].
    Penit-Soria J; Retaux S; Maurin Y
    C R Acad Sci III; 1989; 309(10):441-6. PubMed ID: 2514970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
    de Belleroche J; Gardiner IM
    J Neural Transm; 1983; 58(3-4):153-68. PubMed ID: 6141217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--I. In vivo analysis.
    Nisenbaum ES; Berger TW
    Neuroscience; 1992; 48(3):561-78. PubMed ID: 1318517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of apomorphine and pergolide on the potassium-evoked overflow of GABA in rat striatum studied by microdialysis.
    Tossman U; Ungerstedt U
    Eur J Pharmacol; 1986 Apr; 123(2):295-8. PubMed ID: 3709666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of dopaminergic receptors in quinolinate-induced striatal lesions.
    Wahl F; Plotkine M; Boulu R; Obrenovitch T; Symon L
    Neuroreport; 1993 Nov; 5(2):151-3. PubMed ID: 7906558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric study in vitro.
    Bull DR; Bakhtiar R; Sheehan MJ
    Neurosci Lett; 1991 Dec; 134(1):41-4. PubMed ID: 1687698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
    Takaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
    PrzegaliĊ„ski E; Jaworska L; Konarska R; GoĊ‚embiowska K
    Neuropeptides; 1991 Jul; 19(3):189-95. PubMed ID: 1680223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTH-(1-24) enhances the electrically stimulated release of [3H]dopamine from rat septal slices via a dopamine D2 receptor-independent mechanism.
    Florijn WJ; Versteeg DH
    Brain Res; 1989 Aug; 494(2):247-54. PubMed ID: 2550107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S; Yokoo H; Nishi S
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine.
    Harsing LG; Zigmond MJ
    Brain Res; 1996 Oct; 738(1):142-5. PubMed ID: 8949937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
    Henselmans JM; Hoogland PV; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic observation of dopamine autoreceptor effects in rat striatal slices.
    Kennedy RT; Jones SR; Wightman RM
    J Neurochem; 1992 Aug; 59(2):449-55. PubMed ID: 1352798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
    Stoof JC; Kebabian JW
    Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.